SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-008749
Filing Date
2021-05-04
Accepted
2021-05-04 07:44:42
Documents
86
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lnth-20210331.htm   iXBRL 10-Q 1393256
2 EX-31.1 lnth10q-033121ex311.htm EX-31.1 11770
3 EX-31.2 lnth10q-033121ex312.htm EX-31.2 11689
4 EX-32.1 lnth10q-033121ex321.htm EX-32.1 9879
  Complete submission text file 0001628280-21-008749.txt   7229019

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20210331.xsd EX-101.SCH 48076
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20210331_cal.xml EX-101.CAL 117049
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20210331_def.xml EX-101.DEF 225009
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20210331_lab.xml EX-101.LAB 609359
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20210331_pre.xml EX-101.PRE 387760
10 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20210331_htm.xml XML 1304713
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 21886030
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences